CorVel Corp

CorVel Corp(CRVL)股票分析

$81.310

+1.618 (+1.99%)收盘时

Loading chart…
最高
81.640
开盘
80.700
成交量加权均价
81.18
成交量
124.34K
市值
4.32B
最低
80.580
成交额
10.09M
企业价值/息税折旧摊销前利润(TTM)
0.00

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.

AI 分析 of CorVel Corp (CRVL)

买入

CorVel Corp is a good buy right now due to its recent strong financial performance, with a Q1 net profit of $32.22 million and an EPS of $0.63, both showing significant year-over-year growth. Additionally, the RSI is at 77.48, indicating strong momentum, while the stock has shown a 21.22% year-to-date increase, reflecting positive market sentiment. The main risk is the high forward P/E of 23.75, suggesting that the stock may be overvalued if growth expectations are not met.

估值指标

CorVel Corp(CRVL)当前预期市盈率为 23.75,5 年平均预期市盈率为 91.04。

预期市盈率

低估
5 年均值 P/E
91.04
当前P/E
23.75
高估
130.81
低估
51.27

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
0.00
当前EV/EBITDA
0.00
高估
0.00
低估
0.00

预期市销率

严重低估
5 年均值 P/S
7.02
当前P/S
0.00
高估
8.94
低估
5.09

持有 CRVL 的大户

K

Kayne Anderson Rudnick Investment Management, LLC

+ 持有CRVL

-2.31%

3个月收益率

事件时间线

2026-06-01 (ET)

16:40:00

CorVel Appoints Sarah Scott as CEO

2026-05-20 (ET)

06:20:00

Q4 Revenue Reaches $248.54M

2026-02-03 (ET)

06:20:00

Q3 Revenue Reaches $236M vs. $228M Last Year

2025-02-13 (ET)

06:36:59

CorVel appoints Scott as Executive Vice President of Product

2024-12-24 (ET)

12:16:10

CorVel announces effectiveness of three-for-one forward stock split

资讯

CRVL 常见问题 —— 由 Alphio AI 解答

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner. It operates in the Healthcare sector (INSURANCE AGENTS, BROKERS & SERVICE industry).

CorVel Corp is a good buy right now due to its recent strong financial performance, with a Q1 net profit of $32.22 million and an EPS of $0.63, both showing significant year-over-year growth. Additionally, the RSI is at 77.48, indicating strong momentum, while the stock has shown a 21.22% year-to-date increase, reflecting positive market sentiment. The main risk is the high forward P/E of 23.75, suggesting that the stock may be overvalued if growth expectations are not met.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易